DSIJ Mindshare

Unichem Labs gains 3 per cent on receiving USFDA tentative nod for Aripiprazole tablets

Anthony Fernandes 0 597 Article rating: 5.0

The shares of Unichem Laboratories Limited were trading higher today by 3 per cent intraday after the company announced that it has received tentative approval from United States Food & Drug Administration (USFDA) for Aripiprazole tablets in the strengths of 2 mg, 5 mg, 10 mg, 15 mg, 20 mg and 30 mg.   

Google & Jio Platforms develop ‘most affordable smartphone; plan to launch later this year

Anthony Fernandes 0 594 Article rating: 4.9

Reliance Industries Limited (RIL) announced that its digital subsidiary, Jio Platforms Limited and Google have come together to jointly develop a made-for-India smartphone called JioPhone Next, which is to launch later this year (in September). 

Vardhman Special Steels rises over 3 per cent on getting environmental clearance for Ludhiana expansion

Anthony Fernandes 0 1447 Article rating: 4.6

The shares of Vardhman Special Steels Limited (VSSL) were trading higher by over 3 per cent intraday after the company informed the exchanges that the Ministry of Environment granted the long-awaited environmental clearance for the expansion of capacity at its existing plant in Ludhiana, up to 2,80,000 tonnes per annum of rolled production.  

RSS
First678911131415Last
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR